The University of Chicago Header Logo

Connection

John Fung to Kidney Transplantation

This is a "connection" page, showing publications John Fung has written about Kidney Transplantation.
Connection Strength

3.430
  1. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
    View in: PubMed
    Score: 0.162
  2. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation. 2004 Mar 27; 77(6):897-902.
    View in: PubMed
    Score: 0.143
  3. Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation. Prog Transplant. 2023 Dec; 33(4):363-371.
    View in: PubMed
    Score: 0.140
  4. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 2002 Sep; 8(9):841-5.
    View in: PubMed
    Score: 0.128
  5. Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. Transplant Proc. 2002 Aug; 34(5):1540-1.
    View in: PubMed
    Score: 0.128
  6. Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial. Transplantation. 2022 05 01; 106(5):997-1003.
    View in: PubMed
    Score: 0.119
  7. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation. 2001 Jan 27; 71(2):267-71.
    View in: PubMed
    Score: 0.115
  8. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc. 2000 May; 32(3):663-4.
    View in: PubMed
    Score: 0.109
  9. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.103
  10. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord. 1999 Jun; 9(2):101-3.
    View in: PubMed
    Score: 0.103
  11. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
    View in: PubMed
    Score: 0.102
  12. Immunosuppressive therapy. Surg Clin North Am. 1999 Feb; 79(1):59-76.
    View in: PubMed
    Score: 0.100
  13. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc. 1999 Feb-Mar; 31(1-2):700-1.
    View in: PubMed
    Score: 0.100
  14. The politics of grafting cadaver kidneys. Lancet. 1996 Aug 17; 348(9025):454-5.
    View in: PubMed
    Score: 0.085
  15. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation. 1994 Mar 27; 57(6):860-5.
    View in: PubMed
    Score: 0.072
  16. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
    View in: PubMed
    Score: 0.070
  17. Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery. 2012 Sep; 152(3):376-81.
    View in: PubMed
    Score: 0.064
  18. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.059
  19. Overview of FK506 in transplantation. Clin Transpl. 1990; 115-21.
    View in: PubMed
    Score: 0.053
  20. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation. 2007 Mar 15; 83(5):656-62.
    View in: PubMed
    Score: 0.044
  21. Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience. Transplant Proc. 2005 Dec; 37(10):4436-7.
    View in: PubMed
    Score: 0.040
  22. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg. 2005 Apr; 200(4):505-15; quiz A59-61.
    View in: PubMed
    Score: 0.038
  23. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
    View in: PubMed
    Score: 0.038
  24. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation. 2004 Dec 15; 78(11):1683-8.
    View in: PubMed
    Score: 0.038
  25. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004 Mar; 6(1):10-4.
    View in: PubMed
    Score: 0.036
  26. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg. 2003 Oct; 238(4):520-5; discussion 525-7.
    View in: PubMed
    Score: 0.035
  27. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003 May 03; 361(9368):1502-10.
    View in: PubMed
    Score: 0.034
  28. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc. 2002 Aug; 34(5):1651-2.
    View in: PubMed
    Score: 0.032
  29. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy. 2002 Feb; 22(2):184-7.
    View in: PubMed
    Score: 0.031
  30. A tribute to Thomas E. Starzl, MD, PHD. Am J Transplant. 2002 Jan; 2(1):4-6.
    View in: PubMed
    Score: 0.031
  31. An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant. 2001 May; 1(1):47-50.
    View in: PubMed
    Score: 0.029
  32. Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1134-5.
    View in: PubMed
    Score: 0.029
  33. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1235-6.
    View in: PubMed
    Score: 0.029
  34. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 2000 Sep 15; 70(5):760-4.
    View in: PubMed
    Score: 0.028
  35. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.027
  36. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg. 1999 Sep; 230(3):372-9; discussion 379-81.
    View in: PubMed
    Score: 0.026
  37. Posttransplant diabetes in pediatric recipients on tacrolimus. Transplantation. 1999 Mar 15; 67(5):771.
    View in: PubMed
    Score: 0.025
  38. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
    View in: PubMed
    Score: 0.025
  39. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc. 1999 Feb-Mar; 31(1-2):1134.
    View in: PubMed
    Score: 0.025
  40. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation. 1999 Jan 27; 67(2):299-303.
    View in: PubMed
    Score: 0.025
  41. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl. 1999; 217-21.
    View in: PubMed
    Score: 0.025
  42. A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol. 1998 Dec; 160(6 Pt 1):1982-5; discussion 1985-6.
    View in: PubMed
    Score: 0.025
  43. Reducing the length of stay after kidney transplantation--the intensive outpatient unit. Clin Transplant. 1998 Oct; 12(5):482-5.
    View in: PubMed
    Score: 0.024
  44. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis. 1998 Jun; 31(6 Suppl 1):S7-14.
    View in: PubMed
    Score: 0.024
  45. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
    View in: PubMed
    Score: 0.024
  46. Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1375-7.
    View in: PubMed
    Score: 0.024
  47. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc. 1998 Mar; 30(2):521.
    View in: PubMed
    Score: 0.024
  48. Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc. 1997 Dec; 29(8):3731-2.
    View in: PubMed
    Score: 0.023
  49. Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. Transplant Proc. 1997 Sep; 29(6):2737-8.
    View in: PubMed
    Score: 0.023
  50. An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc. 1997 Jun; 29(4):2238-9.
    View in: PubMed
    Score: 0.022
  51. Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation. 1997 Feb 15; 63(3):471-2.
    View in: PubMed
    Score: 0.022
  52. Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):306.
    View in: PubMed
    Score: 0.022
  53. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):310.
    View in: PubMed
    Score: 0.022
  54. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
    View in: PubMed
    Score: 0.022
  55. "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation. 1996 Nov 15; 62(9):1242-6.
    View in: PubMed
    Score: 0.021
  56. Tacrolimus in renal transplantation. Transplant Proc. 1996 Aug; 28(4):2117-8.
    View in: PubMed
    Score: 0.021
  57. Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc. 1996 Aug; 28(4):2119-20.
    View in: PubMed
    Score: 0.021
  58. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc. 1996 Jun; 28(3):1229-34.
    View in: PubMed
    Score: 0.021
  59. Human islet transplantation: results of the first 37 patients. Transplant Proc. 1995 Dec; 27(6):3162-3.
    View in: PubMed
    Score: 0.020
  60. Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc. 1995 Oct; 27(5):2898.
    View in: PubMed
    Score: 0.020
  61. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation. 1995 Feb 27; 59(4):485-90.
    View in: PubMed
    Score: 0.019
  62. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
    View in: PubMed
    Score: 0.019
  63. Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc. 1995 Feb; 27(1):207-9.
    View in: PubMed
    Score: 0.019
  64. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
    View in: PubMed
    Score: 0.019
  65. FK 506 in solid organ transplantation. Transplant Proc. 1994 Oct; 26(5):3017-20.
    View in: PubMed
    Score: 0.019
  66. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4.
    View in: PubMed
    Score: 0.017
  67. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2435.
    View in: PubMed
    Score: 0.017
  68. Posttransplant hypertension in blacks versus nonblacks. Transplant Proc. 1993 Aug; 25(4):2456-7.
    View in: PubMed
    Score: 0.017
  69. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc. 1993 Feb; 25(1 Pt 1):669-72.
    View in: PubMed
    Score: 0.017
  70. Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc. 1992 Dec; 24(6):3038-9.
    View in: PubMed
    Score: 0.016
  71. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.016
  72. Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol. 1992 May; 140(5):1255-60.
    View in: PubMed
    Score: 0.016
  73. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis. 1992 Feb; 12(1):51-9.
    View in: PubMed
    Score: 0.015
  74. Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc. 1990 Feb; 22(1):25-34.
    View in: PubMed
    Score: 0.013
  75. The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Clin Transpl. 1989; 287-93.
    View in: PubMed
    Score: 0.012
  76. Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron. 1987; 46 Suppl 1:19-33.
    View in: PubMed
    Score: 0.011
  77. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron. 1987; 46 Suppl 1:56-9.
    View in: PubMed
    Score: 0.011
  78. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002 Aug; 2(7):575-80.
    View in: PubMed
    Score: 0.008
  79. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol. 1999 Aug; 66(2):310-4.
    View in: PubMed
    Score: 0.006
  80. Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation. 1999 Jan 27; 67(2):266-72.
    View in: PubMed
    Score: 0.006
  81. Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
    View in: PubMed
    Score: 0.006
  82. Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc. 1997 May; 29(3):1905-6.
    View in: PubMed
    Score: 0.006
  83. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1184-5.
    View in: PubMed
    Score: 0.005
  84. Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy. Transplant Proc. 1997 Feb-Mar; 29(1-2):674-5.
    View in: PubMed
    Score: 0.005
  85. Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc. 1997 Feb-Mar; 29(1-2):746-7.
    View in: PubMed
    Score: 0.005
  86. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
    View in: PubMed
    Score: 0.005
  87. Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc. 1995 Dec; 27(6):3055-6.
    View in: PubMed
    Score: 0.005
  88. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc. 1995 Feb; 27(1):67-70.
    View in: PubMed
    Score: 0.005
  89. Human islet allotransplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3207.
    View in: PubMed
    Score: 0.004
  90. [Clinical experience with FK 506]. Presse Med. 1991 Nov 27; 20(40):1967-73.
    View in: PubMed
    Score: 0.004
  91. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
    View in: PubMed
    Score: 0.004
  92. Use of FK 506 in pediatric patients. Transplant Proc. 1991 Feb; 23(1 Pt 2):924-7.
    View in: PubMed
    Score: 0.004
  93. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990 Sep; 212(3):295-305; discussion 306-7.
    View in: PubMed
    Score: 0.003
  94. The side effects of FK 506 in humans. Transplant Proc. 1990 Feb; 22(1):35-6.
    View in: PubMed
    Score: 0.003
  95. The antibody crossmatch in liver transplantation. Surgery. 1986 Oct; 100(4):705-15.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.